11/21/2024

Janusmed kön och genus

Janusmed kön och genus – Bascellex

Janusmed kön och genus är ett kunskapsstöd som tillhandahåller information om köns- och genusaspekter på läkemedelsbehandling. Kunskapsstödet är avsedd främst för hälso- och sjukvårdspersonal. Texterna är generella och ska inte ses som behandlingsriktlinjer. Det är alltid behandlande läkare som ansvarar för patientens medicinering.

För att komma till startsidan för Janusmed kön och genus och för att göra sökningar klicka här.

Tillbaka till index
A A
A A

Imikvimod

Imikvimod

Klass : A

Visa all info

Skriv ut

Kontakta oss

  1. Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs. 1999;58:375-90.

  2. Roozeboom MH, Nelemans PJ, Mosterd K, Steijlen PM, Arits AH, Kelleners-Smeets NW. Photodynamic therapy vs topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Br J Dermatol. 2015;172:739-45.

  3. Erlendsson AM, Egekvist H, Lorentzen HF, Philipsen PA, Stausbøl-Grøn B, Stender IM et al. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics. Int J Dermatol. 2016;55:309-16.

  4. Javor S, Chimenti S, Patrizi A, Stingeni L, Pellacani G, Cavicchini S et al. Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study Does gender have a role?. G Ital Dermatol Venereol. 2014;149:199-204.

  5. Sauder DN, Skinner RB, Fox TL, Owens ML. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sex Transm Dis. 2003;30:124-8.

  6. ALDARA (imiquimod). Summary of Product Characteristics. European Medicines Agency (EMA); 2016

  7. Gotovtseva EP, Kapadia AS, Smolensky MH, Lairson DR. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis. Sex Transm Dis. 2008;35:346-51.

  8. Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL et al. Self-administered topical 5% imiquimod cream for external anogenital warts HPV Study Group Human PapillomaVirus. Arch Dermatol. 1998;134:25-30.

  9. Beutner KR, Tyring SK, Trofatter KF, Douglas JM, Spruance S, Owens ML et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother. 1998;42:789-94.

  10. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2017-03-02.]

  1. Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs. 1999;58:375-90.
  2. Roozeboom MH, Nelemans PJ, Mosterd K, Steijlen PM, Arits AH, Kelleners-Smeets NW. Photodynamic therapy vs topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Br J Dermatol. 2015;172:739-45.
  3. Erlendsson AM, Egekvist H, Lorentzen HF, Philipsen PA, Stausbøl-Grøn B, Stender IM et al. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics. Int J Dermatol. 2016;55:309-16.
  4. Javor S, Chimenti S, Patrizi A, Stingeni L, Pellacani G, Cavicchini S et al. Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study Does gender have a role?. G Ital Dermatol Venereol. 2014;149:199-204.
  5. Sauder DN, Skinner RB, Fox TL, Owens ML. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sex Transm Dis. 2003;30:124-8.
  6. ALDARA (imiquimod). Summary of Product Characteristics. European Medicines Agency (EMA); 2016
  7. Gotovtseva EP, Kapadia AS, Smolensky MH, Lairson DR. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis. Sex Transm Dis. 2008;35:346-51.
  8. Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL et al. Self-administered topical 5% imiquimod cream for external anogenital warts HPV Study Group Human PapillomaVirus. Arch Dermatol. 1998;134:25-30.
  9. Beutner KR, Tyring SK, Trofatter KF, Douglas JM, Spruance S, Owens ML et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother. 1998;42:789-94.
  10. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2017-03-02.]